Our Weather Forecast For Medtech Business In 2023
We outline the key medtech takeaways from the Annual J.P. Morgan Healthcare Conference held in January, as well as the medtech trends that we will be...
Source: meddeviceonline.com
John Babitt News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Babitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Babitt Today - Breaking & Trending Today
Report: Sales, financing slow down for medtech firms
The industry faces challenges from inflation to labor shortages, according to an annual report from EY. However, there are grounds for optimism and areas to focus on, such as patching up supply chains.
Source: medcitynews.com
Medtech At A Turning Point The 5 Areas To Address In 2022
From 2020 to 2021, the medtech industry's revenues grew and the industry entered a period of recovery and renewal. However, as 2022 begins and we...
Source: meddeviceonline.com
4 Key Considerations For Onshoring Inbound Medtech Supply Chains
Many medtech supply chains hold a significant amount of redundant inventory, from orthopedic spare parts to unutilized loose instruments. If the...
Source: meddeviceonline.com
Firepower 2021: life sciences M&A falls to one of lowest totals since 2014, as biopharmas refocus on alliances and bolt-on deals
Share this article Share this article NEW YORK, Jan. 11, 2021 /PRNewswire/ -- Life sciences mergers and acquisitions (M&A) activity totaled US$159b in 2020, down from US$306b in 2019, reaching one of the lowest levels since 2014, according to the 2021 EY , launched today. A single megadeal – AstraZeneca's December purchase of Alexion Pharmaceuticals – accounted for a quarter of the annual life sciences M&A spend. Setting aside the challenges of doing diligence and closing deals virtually due to the COVID-19 pandemic, persistently high valuations for biopharma and medtech targets kept man...
Source: prnewswire.com